2026-2030年全球生物技术试剂市场

全球生物技术试剂市场预计将从 2025 年到 2030 年成长至 494.128 亿美元，预测期内复合年增长率为 8.2%。

本报告对全球生物技术试剂市场进行了全面分析，包括市场规模和预测、趋势、成长要素、挑战以及对约 25 家公司的供应商分析。

本报告对当前市场状况、最新趋势和驱动因素以及整体市场环境进行了最新分析。推动市场发展的因素包括：基因组学和蛋白​​质组学应用高精度试剂的产业化、生物製药研发投入的增加、重组和细胞培养试剂架构的战略性崛起、就地检验的增长以及即用型试剂组的普及。

本研究客观地结合了一手和二手讯息，包括来自主要行业相关人员的信息。报告内容涵盖主要企业分析、全面的市场规模数据、区域細項分析以及供应商格局。报告中包含历史资料和预测资料。

本研究指出，人工智慧优化的试剂製备和预测稳定性建模将是未来几年全球生物技术试剂市场成长的关键驱动因素。此外，人源性检测试剂的推出、动物性原料的逐步淘汰以及绿色化学和永续试剂生命週期管理的推广，预计也将产生巨大的市场需求。

目录

第一章执行摘要

第二章 Technavio 分析

• 分析定价、生命週期、顾客购买篮子、采用率和购买标准。
• 输入的重要性及差异化因素
• 混淆因素
• 促进因素和挑战的影响

第三章 市场状况

• 市场生态系统
• 市场特征
• 价值链分析

第四章 市场规模

• 市场的定义
• 市场区隔分析
• 2025年市场规模
• 2025-2030年市场展望

第五章 市场规模与表现

• 2020-2024年全球生物技术试剂市场
• 2020-2024年技术细分市场分析
• 2020-2024年按应用领域分類的细分市场分析
• 2020-2024年产品细分市场分析
• 2020-2024年区域市场分析
• 2020-2024年各国细分市场分析

第六章 定性分析

• 人工智慧的影响：全球生物技术试剂市场
• 地缘政治衝突对全球生物技术试剂市场的影响

第七章：五力分析

• 五力模型概述
• 买方的议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

第八章 市场区隔：依技术划分

• 比较：按技术
• 层析法
• 体外诊断
• 聚合酵素链锁反应
• 细胞培养
• 其他的
• 市场机会：依技术划分

第九章 市场区隔：依应用

• 比较：透过应用
• 蛋白质合成与纯化
• 基因表现
• DNA和RNA分析
• 药物检测
• 市场机会：依应用领域划分

第十章 市场区隔：依产品

• 比较：按产品
• 生命科学试剂
• 分析试剂
• 其他的
• 市场机会：依产品划分

第十一章 客户情况

第十二章 区域情势

• 区域细分
• 区域比较
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 荷兰
• 亚洲
  • 中国
  • 日本
  • 印度
  • 韩国
  • 泰国
  • 印尼
• 世界其他地区
  • 巴西
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 土耳其
  • 阿根廷
  • 哥伦比亚
  • 南非
  • 以色列
• 市场机会：按地区划分

第十三章 促进因素、挑战与机会

• 市场驱动因素
• 市场挑战
• 促进因素和挑战的影响
• 市场机会

第十四章 竞争格局

• 概述
• 竞争格局
• 混乱局面
• 产业风险

第十五章 竞争分析

• 公司简介
• 公司排名指标
• 企业市场定位
• Abbott Laboratories
• Agilent Technologies Inc.
• Beckman Coulter Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• BioMerieux SA
• F. Hoffmann La Roche Ltd.
• Lonza Group Ltd.
• Merck KGaA
• Meridian Bioscience Inc.
• Promega Corp.
• Revvity Inc.
• Siemens AG
• Sysmex Corp.
• Thermo Fisher Scientific Inc.

第十六章附录

The global biotechnology reagents market is forecasted to grow by USD 49412.8 mn during 2025-2030, accelerating at a CAGR of 8.2% during the forecast period. The report on the global biotechnology reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by industrialization of high-fidelity reagents for genomic and proteomic applications, increase in biopharmaceutical development spending and strategic rise of recombinant and cell-culture reagent architectures, growth of point-of-care testing and adoption of ready-to-use reagent kits.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global biotechnology reagents market is segmented as below:

By Technology

• Chromatography
• In-vitro diagnostics
• Polymerase chain reaction
• Cell culture
• Others

By Application

• Protein synthesis and purification
• Gene expression
• DNA and RNA analysis
• Drug testing

By Product

• Life science reagents
• Analytical reagents
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the formulation of ai-optimized reagent and predictive stability modeling as one of the prime reasons driving the global biotechnology reagents market growth during the next few years. Also, introduction of human-relevant testing reagents and strategic phase-out of animal-derived inputs and expansion of green chemistry and sustainable reagent life-cycle management will lead to sizable demand in the market.

The report on the global biotechnology reagents market covers the following areas:

• Global biotechnology reagents market sizing
• Global biotechnology reagents market forecast
• Global biotechnology reagents market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biotechnology reagents market vendors that include Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, F. Hoffmann La Roche Ltd., Illumina Inc., Lonza Group Ltd., Merck KGaA, Meridian Bioscience Inc., New England Biolabs Inc., Promega Corp., QIAGEN N.V., Revvity Inc., Siemens AG, Sysmex Corp., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corp.. Also, the global biotechnology reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Biotechnology Reagents Market 2020 - 2024
  • Historic Market Size - Data Table on Global Biotechnology Reagents Market 2020 - 2024 ($ million)
• 5.2 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.4 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in global biotechnology reagents market
• 6.2 Impact of geopolitical conflict for global biotechnology reagents market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Technology

• 8.1 Market segments
• 8.2 Comparison by Technology
• 8.3 Chromatography - Market size and forecast 2025-2030
• 8.4 In-vitro diagnostics - Market size and forecast 2025-2030
• 8.5 Polymerase chain reaction - Market size and forecast 2025-2030
• 8.6 Cell culture - Market size and forecast 2025-2030
• 8.7 Others - Market size and forecast 2025-2030
• 8.8 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Protein synthesis and purification - Market size and forecast 2025-2030
• 9.4 Gene expression - Market size and forecast 2025-2030
• 9.5 DNA and RNA analysis - Market size and forecast 2025-2030
• 9.6 Drug testing - Market size and forecast 2025-2030
• 9.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by Product

• 10.1 Market segments
• 10.2 Comparison by Product
• 10.3 Life science reagents - Market size and forecast 2025-2030
• 10.4 Analytical reagents - Market size and forecast 2025-2030
• 10.5 Others - Market size and forecast 2025-2030
• 10.6 Market opportunity by Product
  • Market opportunity by Product ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 France - Market size and forecast 2025-2030
  • 12.4.3 UK - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Industrialization of high-fidelity reagents for genomic and proteomic applications
  • Increase in biopharmaceutical development spending and strategic rise of recombinant and cell-culture reagent architectures
  • Growth of point-of-care testing and adoption of ready-to-use reagent kits
• 13.2 Market challenges
  • Disruption of global sourcing networks and implementation of bio-industrial security mandates
  • Complexity of regulatory harmonization amidst introduction of european biotech act
  • Structural cost inflation and fragility of cold-chain logistics for advanced biologics
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Formulation of AI-optimized reagent and predictive stability modeling
  • Introduction of Human-relevant testing reagents and strategic phase-out of animal-derived inputs
  • Expansion of green chemistry and sustainable reagent life-cycle management

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.6 Beckman Coulter Inc.
  • Beckman Coulter Inc. - Overview
  • Beckman Coulter Inc. - Product / Service
  • Beckman Coulter Inc. - Key offerings
  • SWOT
• 15.7 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.8 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.9 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key news
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 15.10 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.11 Lonza Group Ltd.
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key news
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Segment focus
  • SWOT
• 15.12 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.13 Meridian Bioscience Inc.
  • Meridian Bioscience Inc. - Overview
  • Meridian Bioscience Inc. - Product / Service
  • Meridian Bioscience Inc. - Key offerings
  • SWOT
• 15.14 Promega Corp.
  • Promega Corp. - Overview
  • Promega Corp. - Product / Service
  • Promega Corp. - Key offerings
  • SWOT
• 15.15 Revvity Inc.
  • Revvity Inc. - Overview
  • Revvity Inc. - Business segments
  • Revvity Inc. - Key offerings
  • Revvity Inc. - Segment focus
  • SWOT
• 15.16 Siemens AG
  • Siemens AG - Overview
  • Siemens AG - Business segments
  • Siemens AG - Key news
  • Siemens AG - Key offerings
  • Siemens AG - Segment focus
  • SWOT
• 15.17 Sysmex Corp.
  • Sysmex Corp. - Overview
  • Sysmex Corp. - Business segments
  • Sysmex Corp. - Key offerings
  • Sysmex Corp. - Segment focus
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations